LINC02236

Across TCGA pan-cancer cohorts, LINC02236 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC02236 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher LINC02236 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02236 expression acts as an unfavorable survival marker, although some lineages such as ESCA and LUAD show a favorable association.

LIHC, BRCA, and UCEC are the cancer types where LINC02236 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	DFS	Tertile	All	0.166	0.336	.004	66	view →
BRCA	OS	Median	All	0.493	0.651	<.001	64	view →
UCEC	OS	Quartile	II,III,IV	0.651	0.793	.014	32	view →
KIRP	DFS	Tertile	IV	0.043	0.765	.006	24	view →
ESCA	DFS	Quartile	II,III,IV	0.694	0.474	.020	16	view →
LUAD	DFS	Quartile	III,IV	0.763	0.505	.014	13	view →
ACC	OS	Tertile	III,IV	0.977	0.603	.019	11	view →
LGG	OS	Tertile	All	0.734	0.872	.019	8	view →
THCA	DFS	Median	All	0.663	0.889	.024	8	view →
SKCM	DFS	Quartile	III,IV	0.467	0.654	.019	8	view →
BLCA	DFS	Median	All	0.671	0.577	.031	7	view →
SARC	OS	Tertile	All	0.937	0.775	.009	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC02236–LIHC (DFS)

Open the LIHC breakdown →